Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Framework vs Peptivo

Framework
Graded #485

Lower grade

vs+8.5
Peptivo
Graded #330

Higher grade

The verdict

Peptivo takes it — 60.1/100 to 51.6/100.

Peptivo grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Peptivo is a 100% online GLP-1 weight-loss telehealth service offering compounded medication made in the USA at FDA-registered labs, with same-day provider visits and 24/7 messaging.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationPeptivo +13
40
53
Clinical oversightPeptivo +4
72
76
Labs & monitoringPeptivo +13
52
65
FulfillmentPeptivo +17
57
74
Contract termsPeptivo +14
41
55
Framework · left barPeptivo · right bar

The numbers

MetricFrameworkPeptivo
WeighScore51.6/10060.1/100
GradeCC
Scorecard rank#485#330
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Framework

Graded #485 · C

Strengths

  • The compounding pharmacy partner is named, which most of this field does not do
  • Treatment selection is doctor-guided rather than a fixed product menu
  • US-licensed clinicians and a 503A pharmacy pathway

Where it loses points

  • No monthly medication price is published: the tirzepatide and semaglutide pages carry no price at all, and the homepage advertises a per-week figure for 'GLP-1s' generally rather than a rate for either drug
  • The only drug-specific prices anywhere on the site sit on a legacy page — semaglutide at $349 per three months and tirzepatide at $549 per three months
  • A '$75/month with 3-month package' figure is footnoted as a promotion for new GLP-1 users only
  • Different landing pages advertise different per-week rates, $25 on one and $19 on another
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Peptivo

Graded #330 · C

Strengths

  • Low entry pricing — GLP-1 weight-loss plans starting at $169/mo, with free discreet shipping
  • Same-day provider visits and 24/7 provider messaging; 100% online
  • Compounded in the USA at FDA-registered labs; can also prescribe brand GLP-1 (Ozempic, Wegovy, Zepbound)
  • FSA/HSA eligible with upfront pricing

Where it loses points

  • GLP-1 products use generic names ('GLP-1 Daily Support', 'Weight Loss Boost') — semaglutide/tirzepatide not clearly broken out
  • Compounding pharmacy/lab partner not named
  • Limited published policies (privacy and terms only; no HIPAA notice or refund policy found)
  • Not LegitScript-certified (no certification displayed)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard